This course is a deep dive focusing on the eyelids for ocular surface disease success. Anatomy and pathophysiology of the eyelid including ptosis, meibomian gland dysfunction and Demodex blepharitis will highlighted. Digital device use and mask associated dry eye will be covered. This course will describe how compromises to the lids can have a cascading effect on the ocular surface.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Identify how digital device use affects the ocular surface.
Learn strategies to alleviate MADE.
Identify chronic vs. acute neurological disease in ptosis.
Understand the signs and symptoms of Demodex blepharitis.
Identify treatment strategies for incomplete lid seal and dry eye.
Disclosure(s):
Melissa Barnett, OD: ABBOptical: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); AbbVie/Allergan: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Acculens: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Azura Ophthalmics: Advisory Committee/Board Member (); Bausch + Lomb: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); BCLA: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bruder: Advisory Committee/Board Member (); Bruno Vision Care: Advisory Committee/Board Member (); CooperVision: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Dompe: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Epion: Advisory Committee/Board Member (); Gas Permeable Lens Institute: Advisory Committee/Board Member (); Johnson & Johnson Vision: Advisory Committee/Board Member (); Lentechs: Advisory Committee/Board Member (); Ocusoft: Advisory Committee/Board Member (); Orasis: Advisory Committee/Board Member (); Percept: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); RVL: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Sjogren's Syndrome Foundation: Advisory Committee/Board Member (); STAPLE program: Speaker's Bureau (honoraria or other compensation) (); Tarsus: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Thea Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Visus Therapeutics: Advisory Committee/Board Member (), Consulting Fees ()
